Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau

Objective: New diagnostic criteria for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) have been developed using biomarkers aiming to establish whether the clinical syndrome is likely due to underlying AD. We investigated the utility of magnetic resonance imaging (MRI) and cereb...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickerson, Bradford C., Wolk, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795312/
https://www.ncbi.nlm.nih.gov/pubmed/24130528
http://dx.doi.org/10.3389/fnagi.2013.00055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795312/
https://www.ncbi.nlm.nih.gov/pubmed/24130528
http://dx.doi.org/10.3389/fnagi.2013.00055

Ejemplares similares